Cargando…
Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapy for many types of cancer. Genetic disparities between donor and host can result in immune-mediated attack of host tissues, known as graft versus host disease (GVHD), a major cause of morbidity and mortality followin...
Autores principales: | Hippen, Keli L., Hefazi, Mehrdad, Larson, Jemma H., Blazar, Bruce R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366169/ https://www.ncbi.nlm.nih.gov/pubmed/35967386 http://dx.doi.org/10.3389/fimmu.2022.926550 |
Ejemplares similares
-
Effects of MicroRNA on Regulatory T Cells and Implications for Adoptive Cellular Therapy to Ameliorate Graft-versus-Host Disease
por: Hippen, Keli L., et al.
Publicado: (2018) -
Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
por: Hefazi, Mehrdad, et al.
Publicado: (2021) -
Cytolytic CD4(+) and CD8(+) Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022) -
Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
por: Le, Hongnga T., et al.
Publicado: (2020) -
Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)